Adaptin Bio (APTN) Liabilities and Shareholders Equity (2022 - 2026)
Adaptin Bio (APTN) reported Liabilities and Shareholders Equity of $981,452 for Q2 2026, down 41.0% from $1.66 million a year earlier but up 39.0% from the prior quarter.
Powered by 
Analysis
Adaptin Bio (APTN) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Adaptin Bio posted Liabilities and Shareholders Equity of $619,159, up 158.6% from FY2024.
- Liabilities and Shareholders Equity has a three-year compound annual growth rate of 973.9% (FY2022 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $239,415 in FY2024, $380.00 in FY2023 (-24.0%) and $500.00 in FY2022.
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $322.00 in Q2 2024 and a high of $2.85 million in Q1 2025.
- Year over year, Liabilities and Shareholders Equity gained in 1 of the last four quarters, with growth averaging 6.8%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $706,117 (Q1 2026), $619,159 (Q4 2025) and $979,474 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Adaptin Bio | 56.76 Mn | 54.75 Mn | - | 981,452.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 981,452.00 |
| Mar 31, 2026 | 706,117.00 |
| Dec 31, 2025 | 619,159.00 |
| Sep 30, 2025 | 979,474.00 |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 239,415.00 |
| Sep 30, 2024 | 322.00 |
| Jun 30, 2024 | 322.00 |
| Mar 31, 2024 | 380.00 |
| Dec 31, 2023 | 380.00 |
| Sep 30, 2023 | 380.00 |
| Dec 31, 2022 | 500.00 |
API Access
Adaptin Bio Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=APTN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "APTN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=APTN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();